European Federation of Pharmaceutical Industries and Associations

The European Federation of Pharmaceutical Industries and Associations (EFPIA) The Pharmaceutical Research and Manufacturers of America (PhRMA)... 

European Federation of Pharmaceutical Industries and Associations (EFPIA)... 

Following extensive discussions among aU interested parties, such as the national authorities, the EC and the European Federation of Pharmaceutical Industries and Associations (EFPIA), the EC proposed comprehensive reform of the EU pharmaceutical legislation. The amending legislations are ... 

Applicants are free to solicit advice from individual Member States and according to various surveys conducted by the European Federation of Pharmaceutical Industries and Associations, they often do. Apart from the FDA, these surveys reveal, the EU Member States most often consulted are Germany, France, Sweden and the United Kingdom. Flowever, it is often important to secure a pan-European advice. Article 51 of Council Regulation EEC/2309/93 requires the EMEA to provide the Member States and the institutions of the Commimity with the best possible scientific advice on any question relating to the evaluation of the quality, the safety and the efficacy of medicinal products for human... 

European Federation of Pharmaceutical Industries and Associations (EFPIA) With EFPIA membership from sixteen countries in Western Europe, including all of Europe s major research-based pharmaceutical companies, the Federation s work is concerned with the activities of the EMEA. A wide network of experts and country coordinators has been established to ensure that EFPIA s views are represented in ICH guidelines. 

To quote The European Federation of Pharmaceutical Industries and Associations (EFPIA) Policy Statement on the use of animals in research and development, as our biological knowledge increases, so too does the usefulness of nonanimal methods. There are still enormous gaps in our biological knowledge that limit the usefulness of cell culture and computer based research . 

European federation of pharmaceutical industries and associations 1643 European market, generic conversion rates and price 1766... 

Six founding members of ICH are directly involved in the decision-making process. They represent the regulatory bodies and the industry in the European Union, Japan, and the United States. They are the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) in Europe the Ministry of Health Labor and Welfare and the Japan Pharmaceutical Manufacturers Association (JPMA) in Japan the FDA and the Pharmaceutical Research and Manufacturers of America (PhRMA) and a group of observers including WHO, The European Free Trade Area (EFTA represented at ICH by Swissmedic Switzerland), and Canada represented by Health Canada. 

In July 2011, the Innovative Medicines Initiative (IMI) published a call entitled Sustainable Chemistry—Delivering Medicines For The 21st Century . IMI is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations), including the big pharma global corporations as well as small... 

---